Correlation Engine 2.0
Clear Search sequence regions


  • bile (5)
  • bile acid (4)
  • bile salts (2)
  • cholestasis (1)
  • essential (1)
  • glycol (1)
  • humans (1)
  • liver (1)
  • mannitol (1)
  • micelles (1)
  • secretin (1)
  • sodium (1)
  • Sizes of these terms reflect their relevance to your search.

    In 1959, Ivar Sperber contrasted bile formation with that of urine and proposed that water flow into the canalicular conduit is in response to an osmotic, not a hydrostatic, gradient. Early attempts to support the hypothesis using a bile acid, sodium taurocholate, and the hormone secretin to stimulate bile flow led to conflicting data and a moratorium on attempts to further develop the initial proposal. However, current data amplify the initial proposal and indicate both paracellular and transcellular water flow into hepatic ductules and the canalicular conduit in response to an osmotic gradient. Also, the need to further modify the initial proposal became apparent with the recognition that bile acid aggregates (micelles), which form in the canalicular conduit, generate lecithin-cholesterol vesicles that contain water unrelated to an osmotic gradient. As part of this development is the recent introduction of the fluorescent localization after photobleaching technique for direct determination of hepatic duct flow and clarification of the role of biomarkers such as mannitol and polyethylene glycol 900. With the new paradigm, these biomarkers may prove useful for quantifying paracellular and transcellular water flow, respectively. SIGNIFICANCE STATEMENT: It is essential to identify and characterize all the sites for water flow during hepatic bile formation to obtain more precision in evaluating the causes and possible therapeutic approaches to cholestatic syndromes. Updating the Sperber proposal provides a new paradigm that addresses the advances in knowledge that have occurred. Copyright © 2023 by The Author(s).

    Citation

    Norman B Javitt. Hepatic Bile Formation: Developing a New Paradigm. Pharmacological reviews. 2023 Sep;75(5):1036-1042

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37532432

    View Full Text